Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-25-285069
Filing Date
2025-11-17
Accepted
2025-11-17 21:44:24
Documents
2
Period of Report
2025-11-10

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4212
2 EX-24 ck0001800315-ex24.htm EX-24 10777
  Complete submission text file 0001193125-25-285069.txt   16505
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Issuer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET BOSTON MA 02127
Business Address
Bruno Julianne (Reporting) CIK: 0002019645 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39655 | Film No.: 251492631